STAAR Surgical (STAA)
(Delayed Data from NSDQ)
$26.90 USD
-0.12 (-0.44%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $26.87 -0.03 (-0.11%) 7:58 PM ET
4-Sell of 5 4
D Value C Growth B Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
STAA 26.90 -0.12(-0.44%)
Will STAA be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for STAA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for STAA
Staar Surgical (STAA) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
Staar Surgical (STAA) Reports Q2 Loss, Beats Revenue Estimates
STAA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Henry Schein (HSIC) Q2 Earnings Lag Estimates
Staar Surgical (STAA) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
Staar Surgical (STAA) Reports Q1 Loss, Tops Revenue Estimates
Other News for STAA
Stifel gets more bearish on Staar Surgical, downgrades shares
Staar Surgical price target raised to $28 from $20 at Canaccord
STAAR Surgical Non-GAAP EPS of -$0.30 beats by $0.26, revenue of $44.3M beats by $3.38M
Staar Surgical Co (STAA) Q2 2025 Earnings: EPS Loss of $(0.34) Beats Estimate, Revenue of $44. ...
Earnings Scheduled For August 6, 2025